INVESTMENT AGREEMENT by and among LUCKIN COFFEE INC. (IN PROVISIONAL LIQUIDATION) CANNONBALL LIMITED and Joy Capital II, L.P. Dated as of April 15, 2021Investment Agreement • December 9th, 2021 • Centurium Capital Partners 2018, L.P. • Biological products, (no disgnostic substances) • New York
This INVESTMENT AGREEMENT, dated as of April 15, 2021 (this “Agreement”), by and among (i) Luckin Coffee Inc. (in Provisional Liquidation), a Cayman Islands exempted company with company number 324324 (the “Company”), (ii) Cannonball Limited, a Cayman Islands exempted company with company number 355807 and an entity controlled by Affiliate(s) of Centurium Capital Management Ltd. (together with its successors and any Permitted Transferee that becomes a party hereto pursuant to Section 9.03, the “Lead Investor”) and (iii) Joy Capital II, L.P., a Cayman Islands exempted limited partnership (“Joy Capital”, together with the Lead Investor, collectively, the “Investors” and each, an “Investor”).
Joint Filing AgreementJoint Filing Agreement • December 9th, 2021 • Centurium Capital Partners 2018, L.P. • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Class A Ordinary Shares, par value $0.000002 per share (the “Class A Ordinary Shares”) of Luckin Coffee Inc., a Cayman Islands exempted company (the “Issuer”) whose principal executive offices is located at 28th Floor, Building T3, Haixi Jingu Plaza 1-3 Taibei Road Siming District, Xiamen City, Fujian People’s Republic of China, 361008, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 9th, 2021 • Centurium Capital Partners 2018, L.P. • Biological products, (no disgnostic substances) • Hong Kong
